Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2019-04-30 Regulatory Filings
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 90% confidence The document text is extremely short (295 characters) and contains only address and stock exchange listing information without any substantive content, financial data, or report details. It does not contain any report, announcement, or regulatory filing content. Given the lack of any specific report or announcement, and the minimal content, the best fit is Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit elsewhere.
2019-04-30 English
Pursuant to SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November, 2018, in respect of fund raising by issuance of Debt Securities by Large Entity and disclosure and compliance ....
Regulatory Filings
2019-04-30 English
As required under regulation 40 (9) of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we attach herewith a copy of compliance certificate dated 26th April, 2019 ....
Regulatory Filings
2019-04-27 English
Disc. under Reg.30 of SEBI (SAST) Reg.2011
Major Shareholding Notification Classification · 95% confidence The document is a formal disclosure letter addressed to the National Stock Exchange of India Limited. It provides detailed information about the shareholding by the promoter group in Lyka Labs Limited as of March 31, 2019. The disclosure is made under regulation 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The content includes names of promoters, shareholding percentages, warrants, and voting rights. This type of document is a notification of changes or status in major shareholding, not a full financial report or earnings release. It fits the definition of a Major Shareholding Notification (MRQ). The document length and detail support this classification with high confidence.
2019-04-25 English
Updates
Regulatory Filings Classification · 90% confidence The document is extremely short (374 characters) and appears to be an address or header related to stock exchanges with script codes. There is no substantive financial data, no report content, no management discussion, or any detailed information. It looks like a brief notice or header rather than a full report or announcement. Given the brevity and lack of content, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other categories.
2019-04-25 English
In Compliance with Regulation 74 (5) of SEBI (Depositories and Participants) Regulation, 2018 please find enclosed Certificate for the quarter ended 31st March, 2019 received from M/s. ....
Regulatory Filings
2019-04-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.